Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-04
DOI
10.1007/s00415-020-10235-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
- (2020) Finn Sellebjerg et al. CNS DRUGS
- Emerging therapeutic targets for neuromyelitis optica spectrum disorder
- (2020) Lukmanee Tradtrantip et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations
- (2020) Yang Mao-Draayer et al. Nature Reviews Neurology
- 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases
- (2020) Lisa R. Sammaritano et al. Arthritis & Rheumatology
- Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study
- (2020) Yoshiki Takai et al. BRAIN
- Anti- IL-6 therapies for neuromyelitis optica spectrum disorders: A systematic review of safety and efficacy
- (2020) Itay Lotan et al. Current Neuropharmacology
- Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
- (2020) James E. Frampton DRUGS
- Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options
- (2020) Mattia Rosso et al. Expert Review of Neurotherapeutics
- Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
- (2020) Anthony Traboulsee et al. LANCET NEUROLOGY
- Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial
- (2020) Chao Zhang et al. LANCET NEUROLOGY
- Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
- (2020) Masayuki Tahara et al. LANCET NEUROLOGY
- Translating IL-6 biology into effective treatments
- (2020) Ernest H. Choy et al. Nature Reviews Rheumatology
- From Normal Flora to Brain Abscesses: A Review of Streptococcus intermedius
- (2020) Elio Issa et al. Frontiers in Microbiology
- Rituximab, MS, and pregnancy
- (2020) Jessica B. Smith et al. Neurology-Neuroimmunology & Neuroinflammation
- Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG- and MOG-IgG-associated diseases
- (2020) Simone Mader et al. CURRENT OPINION IN NEUROLOGY
- Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedules
- (2020) Benjamin P. Trewin et al. Multiple Sclerosis and Related Disorders
- Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden
- (2019) Kathrine Lederballe Grøn et al. ANNALS OF THE RHEUMATIC DISEASES
- Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica
- (2019) John Soltys et al. JOURNAL OF CLINICAL INVESTIGATION
- Placental passage of eculizumab and complement blockade in a newborn
- (2019) Caroline Duineveld et al. KIDNEY INTERNATIONAL
- Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
- (2019) Sean J. Pittock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placental transfer of tocilizumab in a patient with rheumatoid arthritis
- (2019) Yoshifumi Tada et al. RHEUMATOLOGY
- Targeting the complement system in bacterial meningitis
- (2019) Diederik L H Koelman et al. BRAIN
- Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
- (2019) Bruce A C Cree et al. LANCET
- A new era for neuromyelitis optica spectrum disorder
- (2019) Elizabeth Silbermann et al. LANCET
- Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder
- (2019) Santiago Pardo et al. Multiple Sclerosis and Related Disorders
- Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin‐4 Antibody Diseases
- (2019) Pierre Durozard et al. ANNALS OF NEUROLOGY
- B cells in autoimmune and neurodegenerative central nervous system diseases
- (2019) Joseph J. Sabatino et al. NATURE REVIEWS NEUROSCIENCE
- Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica
- (2019) Richard K. Burt et al. NEUROLOGY
- Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
- (2019) Takashi Yamamura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Effectiveness and tolerability of immunosuppressants and monoclonal antibodies in preventive treatment of neuromyelitis optica spectrum disorders: A systematic review and network meta-analysis
- (2019) Wenjuan Huang et al. Multiple Sclerosis and Related Disorders
- Initiation of rituximab therapy for new onset neuromyelitis optica spectrum disorder during pregnancy
- (2019) Kathleen C. Munger et al. Multiple Sclerosis and Related Disorders
- Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions
- (2019) Kristen M. Krysko et al. Neurology-Neuroimmunology & Neuroinflammation
- Effectiveness of subcutaneous tocilizumab in neuromyelitis optica spectrum disorders
- (2019) Itay Lotan et al. Multiple Sclerosis and Related Disorders
- Treating neuromyelitis optica with azathioprine: 20-year clinical practice
- (2018) Denis Bernardi Bichuetti et al. Multiple Sclerosis Journal
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
- (2018) J. Ciron et al. REVUE NEUROLOGIQUE
- Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders
- (2018) A. Sebastian López-Chiriboga et al. JAMA Neurology
- Treating neuromyelitis optica with azathioprine: 20-year clinical practice
- (2018) Denis Bernardi Bichuetti et al. Multiple Sclerosis Journal
- Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder
- (2018) Maureen A. Mealy et al. Multiple Sclerosis and Related Disorders
- Eculizumab in pregnancy: a narrative overview
- (2018) Laura Sarno et al. JOURNAL OF NEPHROLOGY
- Obstetric outcomes in a Mexican cohort of patients with AQP4-antibody-seropositive neuromyelitis optica
- (2018) Guillermo Delgado-García et al. Multiple Sclerosis and Related Disorders
- Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies
- (2018) Nadja Borisow et al. EPMA Journal
- Blockade of IL-6 signaling in neuromyelitis optica
- (2018) Manabu Araki NEUROCHEMISTRY INTERNATIONAL
- Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD)
- (2018) Yara Dadalti Fragoso et al. Multiple Sclerosis and Related Disorders
- New insights and long-term safety of tocilizumab in rheumatoid arthritis
- (2018) Graeme Jones et al. Therapeutic Advances in Musculoskeletal Disease
- Neuromyelitis Optica
- (2017) Jeffrey L. Bennett et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
- (2017) Zahra Nikoo et al. JOURNAL OF NEUROLOGY
- Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
- (2017) Jan-Patrick Stellmann et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
- (2017) Mark A Agius et al. Multiple Sclerosis Journal
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management
- (2017) Eslam Shosha et al. Multiple Sclerosis Journal
- High risk of postpartum relapses in neuromyelitis optica spectrum disorder
- (2017) Eric C. Klawiter et al. NEUROLOGY
- Low level of Rituximab in human breast milk in a patient treated during lactation
- (2017) Yngvill Bragnes et al. RHEUMATOLOGY
- Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
- (2017) Mark A Agius et al. Multiple Sclerosis Journal
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management
- (2017) Eslam Shosha et al. Multiple Sclerosis Journal
- Low immunogenicity of tocilizumab in patients with rheumatoid arthritis
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China
- (2016) Hongxi Chen et al. CLINICAL NEUROPHARMACOLOGY
- Th17 cells in neuromyelitis optica spectrum disorder: a review
- (2016) Jie Lin et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal Pathway
- (2016) Janus Asbjørn Schatz-Jakobsen et al. JOURNAL OF IMMUNOLOGY
- Comparison of efficacy and tolerability of azathioprine, mycophenolate mofetil, and cyclophosphamide among patients with neuromyelitis optica spectrum disorder: A prospective cohort study
- (2016) Yan Xu et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan
- (2016) Ken Nakajima et al. Modern Rheumatology
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- Rituximab in multiple sclerosis
- (2016) Jonatan Salzer et al. NEUROLOGY
- Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data
- (2016) Maria Hoeltzenbein et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
- (2016) Ding Chen et al. Journal of Clinical Medicine
- The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model
- (2015) Christian Geis et al. EXPERIMENTAL NEUROLOGY
- Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn
- (2015) Randi Fykse Hallstensen et al. IMMUNOBIOLOGY
- Resolution of aquaporin-4 antibodies in a woman with neuromyelitis optica treated with human autologous stem cell transplant
- (2015) Patrick Aouad et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series
- (2015) Laura Azzopardi et al. JOURNAL OF NEUROLOGY
- Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
- (2015) Hélène Zéphir et al. JOURNAL OF NEUROLOGY
- Analysis of the treatment of neuromyelitis optica
- (2015) Jose Torres et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints
- (2015) In Hye Jeong et al. Multiple Sclerosis Journal
- Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
- (2015) M Radaelli et al. Multiple Sclerosis Journal
- Pregnancy outcomes in aquaporin-4–positive neuromyelitis optica spectrum disorder
- (2015) Matthew M. Nour et al. NEUROLOGY
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
- (2015) Richard J. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
- (2015) Marius Ringelstein et al. JAMA Neurology
- Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints
- (2015) In Hye Jeong et al. Multiple Sclerosis Journal
- Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
- (2015) M Radaelli et al. Multiple Sclerosis Journal
- Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare
- (2015) Huifeng Yun et al. Arthritis & Rheumatology
- Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
- (2014) Ramnath Santosh Ramanathan et al. BMC Neurology
- Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab
- (2014) Joanna Kitley et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party
- (2014) Raffaella Greco et al. Multiple Sclerosis Journal
- Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK
- (2014) Liene Elsone et al. Multiple Sclerosis Journal
- Pregnancy outcomes in a woman with neuromyelitis optica
- (2014) N. Asgari et al. NEUROLOGY
- Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study
- (2014) M. Araki et al. NEUROLOGY
- Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica
- (2014) Maureen A. Mealy et al. JAMA Neurology
- The effect of rituximab on vaccine responses in patients with immune thrombocytopenia
- (2013) I. Nazi et al. BLOOD
- Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease
- (2013) Bindia Jharap et al. GUT
- Efficacy of Intravenous Cyclophosphamide Therapy for Neuromyelitis Optica Spectrum Disorder
- (2013) Hiroaki Yaguchi et al. INTERNAL MEDICINE
- Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
- (2013) J. Kitley et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
- (2013) Sean J Pittock et al. LANCET NEUROLOGY
- Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica
- (2013) C.-S. Yang et al. NEUROLOGY
- Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
- (2013) Ilya Ayzenberg et al. JAMA Neurology
- A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
- (2013) Su-Hyun Kim et al. JAMA Neurology
- Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognizeClostridiumABC transporter
- (2012) Michel Varrin-Doyer et al. ANNALS OF NEUROLOGY
- Lack of Response to Pulse Cyclophosphamide in Neuromyelitis Optica
- (2012) Denis B. Bichuetti et al. ARCHIVES OF NEUROLOGY
- Teratogen update: Methotrexate
- (2012) Sara C. Hyoun et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
- (2012) Sven Jarius et al. Journal of Neuroinflammation
- Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica
- (2012) Takashi Kageyama et al. JOURNAL OF NEUROLOGY
- Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
- (2012) Su-Hyun Kim et al. Multiple Sclerosis Journal
- Influence of pregnancy on neuromyelitis optica spectrum disorder
- (2012) W. Kim et al. NEUROLOGY
- Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica
- (2012) Bernd C. Kieseier et al. JAMA Neurology
- Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
- (2011) Hua Zhang et al. ANNALS OF NEUROLOGY
- Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
- (2011) Su-Hyun Kim ARCHIVES OF NEUROLOGY
- IgG Placental Transfer in Healthy and Pathological Pregnancies
- (2011) Patricia Palmeira et al. Clinical & Developmental Immunology
- Impact of rituximab on relapse rate and disability in neuromyelitis optica
- (2011) Gurdesh S Bedi et al. Multiple Sclerosis Journal
- Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
- (2011) C. Costanzi et al. NEUROLOGY
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
- (2011) H. L. Pellkofer et al. NEUROLOGY
- Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
- (2011) Norio Chihara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuromyelitis Optica Treatment
- (2010) Denis Bernardi Bichuetti et al. ARCHIVES OF NEUROLOGY
- Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica
- (2010) Su-Hyun Kim et al. ARCHIVES OF NEUROLOGY
- Relapsing Neuromyelitis Optica: demographic and clinical features in Iranian patients
- (2010) M. A. Sahraian et al. EUROPEAN JOURNAL OF NEUROLOGY
- gp130 at the nexus of inflammation, autoimmunity, and cancer
- (2010) J. S. Silver et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
- (2010) Tomoyuki Igawa et al. NATURE BIOTECHNOLOGY
- Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
- (2010) L. Campbell et al. RHEUMATOLOGY
- Early pregnancy azathioprine use and pregnancy outcomes
- (2009) Brian J. Cleary et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
- (2009) Akiyuki Uzawa et al. JOURNAL OF NEUROLOGY
- Azathioprine treatment during lactation
- (2008) L. A. CHRISTENSEN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment of Neuromyelitis Optica With Rituximab
- (2008) ARCHIVES OF NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started